Jazz Pharmaceuticals | search
Click here to view Jazz Pharmaceuticals news from 60+ newspapers.
Bookmark or Share- Jazz Pharmaceuticals to Showcase Expansive Neuroscience Portfolio at ...Jazz Pharmaceuticals plc (Nasdaq: JAZZ) is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases — often with limited or no therapeutic options. We have a diverse portfolio of marketed ...
- News | Jazz Pharmaceuticals plcMarch 12, 2024. Jazz Pharmaceuticals to Host Virtual Zanidatamab R&D Day on Tuesday, March 19, 2024. February 28, 2024. Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2023 Financial Results and Provides 2024 Financial Guidance.
- Improving Patients' Lives | Jazz PharmaceuticalsBy unlocking biopharmaceutical discoveries to develop novel medicines, we are giving thousands of people around the world the opportunity to redefine what’s possible. Jazz Pharmaceuticals is focused on improving patients’ lives by identifying, developing, and commercializing products that address unmet medical needs.
- Pipeline | Jazz PharmaceuticalsJazz’s GW Pharmaceuticals initiated clinical trials of Epidyolex in Japan in October 2022. The study tests the efficacy and safety of the drug in patients with LGS, DS and TSC.
- Jazz Pharmaceuticals - WikipediaJazz Pharmaceuticals plc (a merger of Jazz Pharmaceuticals, Inc. and Azur Pharma plc) is an American biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003. [2] One of the company's considerable products is the United States Food and Drug Administration (FDA) approved drug Xyrem (sodium oxybate), the sodium ...
More
